These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8613628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma.
    Severien C, Artlich A, Jonas S, Becher G.
    Eur Respir J; 2000 Oct; 16(4):588-92. PubMed ID: 11106196
    [Abstract] [Full Text] [Related]

  • 3. Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients.
    Kurokawa K, Tanaka H, Tanaka S, Abe S.
    Chest; 2001 Dec; 120(6):1822-8. PubMed ID: 11742908
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation.
    Green SA, Malice MP, Tanaka W, Tozzi CA, Reiss TF.
    Thorax; 2004 Feb; 59(2):100-4. PubMed ID: 14760145
    [Abstract] [Full Text] [Related]

  • 6. Difference in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients.
    Suzuki N, Hishinuma T, Abe F, Omata K, Ito S, Sugiyama M, Mizugaki M.
    Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):395-403. PubMed ID: 11060902
    [Abstract] [Full Text] [Related]

  • 7. Urinary leukotriene E4 in bronchial asthma.
    Smith CM, Hawksworth RJ, Thien FC, Christie PE, Lee TH.
    Eur Respir J; 1992 Jun; 5(6):693-9. PubMed ID: 1321055
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans.
    Kumlin M, Stensvad F, Larsson L, Dahlén B, Dahlén SE.
    Clin Exp Allergy; 1995 May; 25(5):467-79. PubMed ID: 7553251
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of urinary leukotriene E4 levels in asymptomatic bronchial asthma].
    Yamamoto H, Kuramitsu K, Houya I, Maruo H, Sakata K, Tabe K, Kimura I, Inoue K, Shibasaki M, Yamamoto K, Sakamoto Y, Matsuo H.
    Arerugi; 1996 Oct; 45(10):1106-11. PubMed ID: 8958657
    [Abstract] [Full Text] [Related]

  • 13. The challenge procedure influences the extent of allergen-induced urinary excretion of leukotriene E4.
    Kumlin M, Dahlén B.
    Clin Exp Allergy; 2000 Apr; 30(4):585-9. PubMed ID: 10718858
    [Abstract] [Full Text] [Related]

  • 14. Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks.
    Oosaki R, Mizushima Y, Kawasaki A, Kashii T, Mita H, Shida T, Akiyama K, Kobayashi M.
    Int Arch Allergy Immunol; 1997 Dec; 114(4):373-8. PubMed ID: 9414142
    [Abstract] [Full Text] [Related]

  • 15. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.
    Yamaguchi T, Ishii T, Yamamoto K, Higashi N, Taniguchi M, Okamoto M.
    Auris Nasus Larynx; 2016 Jun; 43(3):304-8. PubMed ID: 26527517
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity.
    Divekar R, Hagan J, Rank M, Park M, Volcheck G, O'Brien E, Meeusen J, Kita H, Butterfield J.
    J Allergy Clin Immunol Pract; 2016 Jun; 4(4):665-70. PubMed ID: 27080204
    [Abstract] [Full Text] [Related]

  • 17. Recovery of leukotriene E4 from the urine of patients with airway obstruction.
    Drazen JM, O'Brien J, Sparrow D, Weiss ST, Martins MA, Israel E, Fanta CH.
    Am Rev Respir Dis; 1992 Jul; 146(1):104-8. PubMed ID: 1320817
    [Abstract] [Full Text] [Related]

  • 18. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
    Micheletto C, Visconti M, Tognella S, Trevisan F, Dal Negro RW.
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):162-6. PubMed ID: 17626331
    [Abstract] [Full Text] [Related]

  • 19. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
    Higashi N, Taniguchi M, Mita H, Kawagishi Y, Ishii T, Higashi A, Osame M, Akiyama K.
    J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
    [Abstract] [Full Text] [Related]

  • 20. Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha.
    Tanaka H, Saito T, Kurokawa K, Teramoto S, Miyazaki N, Kaneko S, Hashimoto M, Abe S.
    Allergy; 1999 May; 54(5):489-94. PubMed ID: 10380781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.